Target intelligence / Profile preview

MicroRNA 6859-2 (MIR6859-2)

Target
MIR6859-2
Molecular classification
Other (microRNA, small non-coding RNA)
01

Overview

MicroRNA 6859-2 (MIR6859-2) is a human microRNA gene encoding a small, non-coding RNA molecule involved in the regulation of gene expression at the post-transcriptional level[1][3]. Like all microRNAs, MIR6859-2 acts by associating with Argonaute proteins and the RNA-induced silencing complex (RISC) to bind target mRNAs, leading to inhibition of translation or mRNA degradation, typically through imperfect sequence complementarity[2]. The functional mature product of MIR6859-2, miR-6859-3p, has been predicted to suppress the expression of the transcription factor SOX9 in breast cancer cell lines, though the evidence suggests it acts indirectly and with less potency compared to other miRNAs like miR-134-3p and miR-224-3p[1]. While miR-6859-3p can influence gene expression patterns relevant to cancer biology, MIR6859-2 itself is not currently recognized or classified as a druggable or therapeutic target, receptor, enzyme, or other protein of direct pharmacological relevance. There are no known drugs targeting MIR6859-2, and its clinical utility as a biomarker or therapeutic agent has not been established[1][3]. The available information does not indicate any specific safety concerns or therapeutic challenges associated with MIR6859-2. Clarification: - MIR6859-2 is *not a receptor, enzyme, transporter, or classical therapeutic target*, but rather a gene encoding a small regulatory RNA. - It may be referenced in disease contexts associated with altered microRNA expression but is not directly targeted by any approved or experimental drugs. - "MIR6859-2" is the accepted gene symbol; "miR-6859-2" typically refers to the mature or processed microRNA derived from this gene. - There is no evidence for direct ligand or drug interaction, nor is it involved in canonical drug mechanisms of action. Note: MIR6859-2's role in disease and function remains ancillary and regulatory, consistent with microRNA biology, and its main relevance is to gene expression profiling and experimental functional genomics[1][2][3].

Other names
hsa-mir-6859-2miR-6859-2microRNA mir-6859-2MIR6859-2
02

Biological functions

Gene expression regulation (post-transcriptional)
03

Disease associations

Other (possibly cancer-related, specifically breast cancer modulation[1])

Beyond the preview

Go deeper on MicroRNA 6859-2 (MIR6859-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 6859-2 (MIR6859-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call